On Friday, August 10, the Kaiser Family Foundation and the Global Health Policy Center at the Center for Strategic and International Studies (CSIS) held a briefing to assess the major outcomes of the 2018 International AIDS Conference (AIDS 2018), held from July 23-27 in Amsterdam, the Netherlands. The discussion touched…
HIV/AIDSSee more about HIV/AIDS
- view as grid
- view as list
This updated fact sheet provides the latest data on the global HIV/AIDS epidemic, including impact by region, treatment and prevention efforts, and an overview of the U.S. and global responses to the epidemic.
The Global HIV/AIDS Timeline is an ongoing reference tool for the many political, scientific, cultural, and community developments that have occurred over the history of the HIV/AIDS epidemic.
Despite significant successes in addressing HIV/AIDS around the world, including in the United States, many challenges remain—there are more people living with HIV than ever before and millions of new infections each year, and not everyone has access to the care and treatment they need. At the same time, there…
Kaiser/UNAIDS Study Finds Donor Government Funding for HIV Rose to US$8.1 Billion in 2017 due to Shift in Timing of U.S. Support
Donor government disbursements to combat HIV in low- and middle-income countries increased 16 percent from US$7 billion in 2016 to US$8.1 billion in 2017 – though the higher total stems largely from the timing of U.S. funding and is not expected to last, a new report from the Kaiser Family Foundation…
This report, Financing the Response to AIDS in Low- and Middle-Income Countries: International Assistance from Donor Governments in 2016, tracks funding levels of the donor governments that collectively provide the bulk of international assistance for AIDS through bilateral programs and contributions to the Global Fund to Fight AIDS, Tuberculosis and Malaria. The new report, produced as a partnership between the Kaiser Family Foundation and UNAIDS, provides the latest data available on donor funding disbursements based on data provided by governments. It includes their bilateral assistance to low- and middle-income countries and contributions to the Global Fund as well as UNITAID.
This brief provides a side-by-side comparison of changes to PEPFAR’s authorizing legislation over time. It also identifies which authorities are due to expire at the end of FY 2018.
This fact sheet provides information on key HIV testing statistics, testing recommendations as advised by the U.S. Centers for Disease Control and Prevention (CDC), insurance coverage of HIV testing, testing sites and policies, and types of tests available.
Given the Trump Administration’s promotion of short-term limited-duration (STLD) health insurance policies, this brief examines what they mean for people with HIV. The analysis assesses whether people with HIV could enroll in STLD plans by applying to 38 plans across five states and getting in each case. It also assesses whether such plans could meet basic HIV care and treatment needs for someone diagnosed once enrolled. This finding takes on new importance in light of the Administration’s decision not to defend the ACA and to argue for eliminating pre-existing condition protections.